Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000424495 | SCV000532860 | likely benign | not specified | 2016-10-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001466145 | SCV001670144 | likely benign | Brugada syndrome | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348232 | SCV002652274 | likely benign | Cardiovascular phenotype | 2019-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000424495 | SCV005076027 | likely benign | not specified | 2024-04-28 | criteria provided, single submitter | clinical testing |